Skip to content

Added to your cart:

Cart subtotal

View cart (2) Checkout
Best Selling Products Blood Clotting Products Blood Stopping Products Emergency Medical Supplies (EMS Supplies) EMS Supplies and Trauma Supplies Fire Department Medical Supplies Injectable Medications Life-Saving Drugs Prescription Medications & Prescription Drugs Ampule Medications Cosmetic Surgery Supplies Pfizer Injectables Prescription Drugs and Prescription Medications Active Pharmaceutical Ingredients (APIs) IV Bags IV Bags, IV Sets and Injection Medication Vials IV Bags, IV Sets, IV Start Kits

Filters

Availability
Price
$
-
$
$0 $1600
Vendor
Collection
Tags

Tranexamic Acid Injections, Tablets & IV Solutions

Tranexamic Acid

Tranexamic acid injection is a prescription antifibrinolytic agent (a “clot-stabilizing” drug). Its active ingredient, tranexamic acid, is an amino acid that helps slow down bleeding by blocking the breakdown of blood clots. Normally, when the body is bleeding, it forms clots made of fibrin to stop the bleeding. The fibrin clots are gradually dissolved by a natural process called fibrinolysis, which involves an enzyme called plasmin. Tranexamic acid inhibits plasminogen (the precursor to plasmin), preventing fibrin clots from being broken down too quickly. In effect, it allows clots to stay in place longer and reduces ongoing bleeding without causing new clots to form on its own.

Tranexamic Acid Injection & IV Solution (TXA) are advanced, prescription hospital medications designed for rapid, effective control of acute bleeding and life-threatening hemorrhage. Widely used in trauma centers, surgery rooms, emergency departments, and obstetric units, Tranexamic Acid IV halts excessive blood loss by stabilizing blood clots. TXA is the gold standard for trauma bleeding, postpartum hemorrhage, dental procedures, heavy menstrual bleeding, and major surgical operations. Choose Tranexamic Acid Injection for safe, fast-acting blood loss management, improved surgical outcomes, and superior patient recovery.

Uses (Indications)

Tranexamic acid injection is given intravenously to treat or prevent excessive bleeding in various medical situations:

  • Menorrhagia (heavy menstrual bleeding): Can be used intraoperatively during gynecologic surgeries or in severe cases of menstrual bleeding (though oral forms are more common for routine periods).
  • Surgical bleeding: Used prophylactically or as needed during/after major surgeries (cardiac, orthopedic, liver, obstetric, dental, etc.) to reduce blood loss. For example, it is often given during cardiac bypass, orthopaedic joint replacement, or cesarean delivery (postpartum hemorrhage) to lessen bleeding.
  • Trauma and acute bleeding: (Off-label) It may be used in trauma protocols (Massive Transfusion, e.g. CRASH-2 trial in trauma) to reduce bleeding. It’s also given when bleeding is due to dissolution of clots (e.g. after tPA treatment).
  • Other hemorrhagic conditions: Such as bleeding from the nose/mouth, gastrointestinal bleeding, or bleeding following prostate/urinary tract surgery, where stabilizing clots can help. It is also an adjunct in hemophilia patients undergoing dental extractions [6†L39-L47].
  • Consumptive coagulopathies: In some cases of disseminated intravascular coagulation (DIC) with hyperfibrinolysis, tranexamic acid can be used, but only under strict specialist guidance (because DIC involves complex clotting issues).

In summary, tranexamic acid injection is used whenever an experienced physician judges that preventing fibrin clot breakdown will safely control undesirable bleeding.

Purpose

Tranexamic Acid Injection & IV Solution are formulated to rapidly prevent and control severe, acute bleeding in trauma, surgical, obstetric, and dental emergencies. TXA works by blocking the breakdown of blood clots, stabilizing hemostasis, and reducing the risk of death or complications from hemorrhage.

Uses

  • Trauma Care: Life-saving first-line therapy for acute traumatic hemorrhage in accident victims and emergency scenarios.
  • Surgical Procedures: Reduces intraoperative and postoperative blood loss in major surgeries (cardiac, orthopedic, ENT).
  • Postpartum Hemorrhage: Critical management of heavy bleeding after childbirth; recommended by WHO for maternal safety.
  • Heavy Menstrual Bleeding: Rapid treatment for acute menorrhagia when oral therapy is insufficient.
  • Dental Surgery: Controls bleeding during and after dental extractions, especially in patients with bleeding disorders.
  • Liver Cirrhosis and Coagulopathy: Supportive management in selected coagulation disorders as directed by specialists.

Types & Formulations

  • Tranexamic Acid Injection (IV/IM): Sterile solution for intravenous or intramuscular use.
  • Ready-to-Use IV Bags: Pre-mixed solutions for fast infusion in emergency and operative settings.
  • High-Concentration Vials: For dilution and dose customization in critical care.

Popular Brands

  • Cyklokapron® (Pfizer)
  • Transamin® (Daiichi Sankyo)
  • Hemtran®
  • Lysteda® (oral, for reference)
  • Generic TXA Injection (Fresenius Kabi, Hikma, Amneal, Teva)
  • Sandoz Tranexamic Acid Injection

Strengths

  • 100 mg/mL (most common hospital and surgical strength)
  • 500 mg/5 mL ampules or vials
  • 1 g/10 mL vials
  • Pre-mixed 1 g/100 mL IV bags
  • Adjustable by body weight/clinical need

Sizes

  • 5 mL, 10 mL single-dose ampules or vials
  • 100 mL, 250 mL ready-to-infuse IV bags
  • Bulk packs for trauma, surgery, and emergency rooms
  • Convenient, single-use formats for field and ambulance use

Administration and Dosage

Tranexamic acid is administered by slow intravenous injection (IV) or IV infusion. It should only be given by or under supervision of healthcare providers. The solution commonly comes as 100 mg/mL (for example, 500 mg in 5 mL, as noted on the UK product label). Before injection, the skin and vein access are prepared using standard aseptic technique.

Dosage: The exact dose depends on the clinical situation and patient’s size:

  • A typical adult dose is 1,000 mg (10 mL of 100 mg/mL) IV every 6–8 hours while bleeding continues. This corresponds to about 15 mg per kg of body weight per dose (up to ~4–5 doses per day).
  • In surgical or acute settings, 10–15 mg/kg IV over 10–20 minutes is often used. For example, a heart surgery protocol might use 10–15 mg/kg IV before incision, sometimes followed by additional doses or infusion.
  • For severe bleeding or trauma, an initial bolus (e.g. 1–2 g IV) may be given, followed by continuous infusion as per trauma protocols (some guidelines recommend a total of ~3 g over 24 hours). (Recent studies have shown benefit in trauma when given early.)
  • Children: Doses are weight-based. For example, a child bleeding severely might receive about 10–15 mg/kg IV every 6–8 hours. Oral dosing is an option for less acute situations (liquid or tablets), but the question specifically addresses injection.
  • Renal impairment: Dosage should be reduced in moderate-to-severe kidney failure (since tranexamic acid is excreted by the kidneys). Elderly patients and those with kidney issues typically require dose adjustment.
  • Administration: Tranexamic acid must be given slowly. A rapid IV push can cause hypotension. The patient information leaflet states: “Tranexamic Acid Solution for Injection should only be administered slowly into a vein.”. Never inject it into a muscle or skin. Use infusion pumps or slow push over 10–20 minutes if needed.

All doses and frequency are determined by the treating physician based on bleeding severity and patient factors. The medication is usually given in a hospital or clinical setting with vital sign monitoring.

Side Effects and Precautions

Because tranexamic acid affects clot stability, certain side effects and cautions apply:

  • Clotting risk: Theoretically, anything that stabilizes clots could increase clot risk. In practice, serious clotting events (thrombosis) are rare with tranexamic acid, but the drug is contraindicated in patients who have active intravascular clots or a history of conditions that predispose to clots (deep vein thrombosis, pulmonary embolism, cerebral thrombosis, etc.). It should be used with caution in patients with risk factors for thrombosis (e.g. smoking, pregnancy, estrogen use) and not at all if they have DIC (systemic clotting) or a history of arterial clots. Reportedly, rare cases of stroke or blood clots have occurred, so it is crucial that bleeding is due to high fibrinolysis (breakdown) and not normal clotting. If any clot-related symptoms (limb pain/swelling, chest pain, neurological deficit) occur, treatment must stop and medical evaluation is needed.

  • Allergic reactions: Some people can be allergic to tranexamic acid. Symptoms of allergy include rash, itching, hives, difficulty breathing, or swelling of face/lips.. True anaphylaxis is very rare but has been reported. If any sign of allergy appears during the injection, it should be stopped immediately.

  • Hypotension: Rapid injection of tranexamic acid can cause a sudden drop in blood pressure. Always inject slowly with the patient lying down or closely monitored to avoid this. If hypotension occurs, support blood pressure as needed.

  • Neurological: High doses or very rapid infusion may cause seizures (convulsions). Therefore, the lowest effective dose should be used. The UK leaflet specifically warns: “Tranexamic acid solution should not be administered [IV] if you have a history of convulsions…Your doctor must use the minimal dose possible to avoid convulsions.”. Rarely, visual disturbances have been reported (blurry vision or color changes), especially with long-term use. If vision problems occur, the drug should be discontinued and an ophthalmologist consulted.

  • Other side effects: Common side effects may include nausea, vomiting, diarrhea, or abdominal discomfort. These are usually mild. Less common effects include headache or dizziness. Very rarely, patients may develop muscle spasms (related to altered amino acid levels). The patient leaflet also lists rare effects like joint or muscle pain. In research trials, serious side effects beyond those noted above were uncommon.

  • Renal caution: Since tranexamic acid is excreted by the kidneys, those with impaired renal function need dose adjustments (as above). In kidney failure, accumulation may increase seizure risk.

  • Other precautions: Tell your doctor if you have any problems with blood clotting, if you have a history of eye disease, or neurological conditions. Tranexamic acid can interact with other drugs, particularly clotting factors or thrombolytics: it is contraindicated with prothrombin complex concentrate or factor IX products (risk of clot). Also, if you take hormonal birth control or estrogen, mention it because both can modestly increase clot risk, although the combination is not absolutely contraindicated (but caution is advised).

In case of overdose, symptoms would mainly be hypotension or clotting issues. There is no specific antidote, so treatment is symptomatic and supportive (manage blood pressure, watch kidney function, etc.).

Key Points and Safe Use

  • Tranexamic acid injection (often known by the brand Cyklokapron) is used to prevent or reduce bleeding by blocking the breakdown of clots. It’s given intravenously by trained professionals only (e.g. during surgery or heavy bleeding events).
  • It is commonly dosed at 1 gram IV slowly every 6–8 hours (or 15 mg/kg per dose) for adults, depending on the situation. Pediatric doses are weight-based (about 10–15 mg/kg). Always double-check dosing, especially in children or kidney-impaired patients.
  • Watch for clots: The main risk is unwanted thrombosis. Avoid using it in patients who have active clots, DIC, or serious risk of clots. Monitor for any sign of clot (leg pain/swelling, breathing trouble, chest pain).
  • Allergy: Rare severe allergic reactions can occur. Be ready to treat anaphylaxis if needed (oxygen, epinephrine, etc.) when giving any IV medication.
  • Administration: Inject slowly (generally over 10 minutes or via infusion pump). Rapid injection can cause dangerous hypotension. Do not inject into muscle or elsewhere besides a vein. Always use aseptic technique and properly dispose of needles.
  • Later effects: Inform your doctor of any change in vision or severe headache during therapy. Long-term use (if ever needed) requires eye exams and watching for visual changes.

Disclaimer: I am not a doctor. The information below is for general knowledge and not medical advice. Always follow a healthcare provider’s directions.

People Also Searched For

Tranexamic Acid Injections, Tablets & IV Solutions to doctor-only Tranexamic Acid Injections, Tablets & IV Solutions to Tranexamic Acid Tranexamic Acid Injections, Tablets & IV Solutions to Antifibrinolytic Agent Tranexamic Acid Injections, Tablets & IV Solutions to Heavy Blood Loss Tranexamic Acid Injections, Tablets & IV Solutions to Emergency Medical Supplies Tranexamic Acid Injections, Tablets & IV Solutions to Emergency Responders Tranexamic Acid Injections, Tablets & IV Solutions to EMS Tranexamic Acid Injections, Tablets & IV Solutions to Loss of Blood Tranexamic Acid Injections, Tablets & IV Solutions to Stop bleeding Tranexamic Acid Injections, Tablets & IV Solutions to Bleeding disorders

Tranexamic Acid

Tranexamic acid injection is a prescription antifibrinolytic agent (a “clot-stabilizing” drug). Its active ingredient, tranexamic acid, is an amino acid that helps slow down bleeding by blocking the breakdown of blood clots. Normally, when the body is bleeding, it forms clots made of fibrin to stop the bleeding. The fibrin clots are gradually dissolved by a natural process called fibrinolysis, which involves an enzyme called plasmin. Tranexamic acid inhibits plasminogen (the precursor to plasmin), preventing fibrin clots from being broken down too quickly. In effect, it allows clots to stay in place longer and reduces ongoing bleeding without causing new clots to form on its own.

Tranexamic Acid Injection & IV Solution (TXA) are advanced, prescription hospital medications designed for rapid, effective control of acute bleeding and life-threatening hemorrhage. Widely used in trauma centers, surgery rooms, emergency departments, and obstetric units, Tranexamic Acid IV halts excessive blood loss by stabilizing blood clots. TXA is the gold standard for trauma bleeding, postpartum hemorrhage, dental procedures, heavy menstrual bleeding, and major surgical operations. Choose Tranexamic Acid Injection for safe, fast-acting blood loss management, improved surgical outcomes, and superior patient recovery.

Uses (Indications)

Tranexamic acid injection is given intravenously to treat or prevent excessive bleeding in various medical situations:

  • Menorrhagia (heavy menstrual bleeding): Can be used intraoperatively during gynecologic surgeries or in severe cases of menstrual bleeding (though oral forms are more common for routine periods).
  • Surgical bleeding: Used prophylactically or as needed during/after major surgeries (cardiac, orthopedic, liver, obstetric, dental, etc.) to reduce blood loss. For example, it is often given during cardiac bypass, orthopaedic joint replacement, or cesarean delivery (postpartum hemorrhage) to lessen bleeding.
  • Trauma and acute bleeding: (Off-label) It may be used in trauma protocols (Massive Transfusion, e.g. CRASH-2 trial in trauma) to reduce bleeding. It’s also given when bleeding is due to dissolution of clots (e.g. after tPA treatment).
  • Other hemorrhagic conditions: Such as bleeding from the nose/mouth, gastrointestinal bleeding, or bleeding following prostate/urinary tract surgery, where stabilizing clots can help. It is also an adjunct in hemophilia patients undergoing dental extractions [6†L39-L47].
  • Consumptive coagulopathies: In some cases of disseminated intravascular coagulation (DIC) with hyperfibrinolysis, tranexamic acid can be used, but only under strict specialist guidance (because DIC involves complex clotting issues).

In summary, tranexamic acid injection is used whenever an experienced physician judges that preventing fibrin clot breakdown will safely control undesirable bleeding.

Purpose

Tranexamic Acid Injection & IV Solution are formulated to rapidly prevent and control severe, acute bleeding in trauma, surgical, obstetric, and dental emergencies. TXA works by blocking the breakdown of blood clots, stabilizing hemostasis, and reducing the risk of death or complications from hemorrhage.

Uses

  • Trauma Care: Life-saving first-line therapy for acute traumatic hemorrhage in accident victims and emergency scenarios.
  • Surgical Procedures: Reduces intraoperative and postoperative blood loss in major surgeries (cardiac, orthopedic, ENT).
  • Postpartum Hemorrhage: Critical management of heavy bleeding after childbirth; recommended by WHO for maternal safety.
  • Heavy Menstrual Bleeding: Rapid treatment for acute menorrhagia when oral therapy is insufficient.
  • Dental Surgery: Controls bleeding during and after dental extractions, especially in patients with bleeding disorders.
  • Liver Cirrhosis and Coagulopathy: Supportive management in selected coagulation disorders as directed by specialists.

Types & Formulations

  • Tranexamic Acid Injection (IV/IM): Sterile solution for intravenous or intramuscular use.
  • Ready-to-Use IV Bags: Pre-mixed solutions for fast infusion in emergency and operative settings.
  • High-Concentration Vials: For dilution and dose customization in critical care.

Popular Brands

  • Cyklokapron® (Pfizer)
  • Transamin® (Daiichi Sankyo)
  • Hemtran®
  • Lysteda® (oral, for reference)
  • Generic TXA Injection (Fresenius Kabi, Hikma, Amneal, Teva)
  • Sandoz Tranexamic Acid Injection

Strengths

  • 100 mg/mL (most common hospital and surgical strength)
  • 500 mg/5 mL ampules or vials
  • 1 g/10 mL vials
  • Pre-mixed 1 g/100 mL IV bags
  • Adjustable by body weight/clinical need

Sizes

  • 5 mL, 10 mL single-dose ampules or vials
  • 100 mL, 250 mL ready-to-infuse IV bags
  • Bulk packs for trauma, surgery, and emergency rooms
  • Convenient, single-use formats for field and ambulance use

Administration and Dosage

Tranexamic acid is administered by slow intravenous injection (IV) or IV infusion. It should only be given by or under supervision of healthcare providers. The solution commonly comes as 100 mg/mL (for example, 500 mg in 5 mL, as noted on the UK product label). Before injection, the skin and vein access are prepared using standard aseptic technique.

Dosage: The exact dose depends on the clinical situation and patient’s size:

  • A typical adult dose is 1,000 mg (10 mL of 100 mg/mL) IV every 6–8 hours while bleeding continues. This corresponds to about 15 mg per kg of body weight per dose (up to ~4–5 doses per day).
  • In surgical or acute settings, 10–15 mg/kg IV over 10–20 minutes is often used. For example, a heart surgery protocol might use 10–15 mg/kg IV before incision, sometimes followed by additional doses or infusion.
  • For severe bleeding or trauma, an initial bolus (e.g. 1–2 g IV) may be given, followed by continuous infusion as per trauma protocols (some guidelines recommend a total of ~3 g over 24 hours). (Recent studies have shown benefit in trauma when given early.)
  • Children: Doses are weight-based. For example, a child bleeding severely might receive about 10–15 mg/kg IV every 6–8 hours. Oral dosing is an option for less acute situations (liquid or tablets), but the question specifically addresses injection.
  • Renal impairment: Dosage should be reduced in moderate-to-severe kidney failure (since tranexamic acid is excreted by the kidneys). Elderly patients and those with kidney issues typically require dose adjustment.
  • Administration: Tranexamic acid must be given slowly. A rapid IV push can cause hypotension. The patient information leaflet states: “Tranexamic Acid Solution for Injection should only be administered slowly into a vein.”. Never inject it into a muscle or skin. Use infusion pumps or slow push over 10–20 minutes if needed.

All doses and frequency are determined by the treating physician based on bleeding severity and patient factors. The medication is usually given in a hospital or clinical setting with vital sign monitoring.

Side Effects and Precautions

Because tranexamic acid affects clot stability, certain side effects and cautions apply:

  • Clotting risk: Theoretically, anything that stabilizes clots could increase clot risk. In practice, serious clotting events (thrombosis) are rare with tranexamic acid, but the drug is contraindicated in patients who have active intravascular clots or a history of conditions that predispose to clots (deep vein thrombosis, pulmonary embolism, cerebral thrombosis, etc.). It should be used with caution in patients with risk factors for thrombosis (e.g. smoking, pregnancy, estrogen use) and not at all if they have DIC (systemic clotting) or a history of arterial clots. Reportedly, rare cases of stroke or blood clots have occurred, so it is crucial that bleeding is due to high fibrinolysis (breakdown) and not normal clotting. If any clot-related symptoms (limb pain/swelling, chest pain, neurological deficit) occur, treatment must stop and medical evaluation is needed.

  • Allergic reactions: Some people can be allergic to tranexamic acid. Symptoms of allergy include rash, itching, hives, difficulty breathing, or swelling of face/lips.. True anaphylaxis is very rare but has been reported. If any sign of allergy appears during the injection, it should be stopped immediately.

  • Hypotension: Rapid injection of tranexamic acid can cause a sudden drop in blood pressure. Always inject slowly with the patient lying down or closely monitored to avoid this. If hypotension occurs, support blood pressure as needed.

  • Neurological: High doses or very rapid infusion may cause seizures (convulsions). Therefore, the lowest effective dose should be used. The UK leaflet specifically warns: “Tranexamic acid solution should not be administered [IV] if you have a history of convulsions…Your doctor must use the minimal dose possible to avoid convulsions.”. Rarely, visual disturbances have been reported (blurry vision or color changes), especially with long-term use. If vision problems occur, the drug should be discontinued and an ophthalmologist consulted.

  • Other side effects: Common side effects may include nausea, vomiting, diarrhea, or abdominal discomfort. These are usually mild. Less common effects include headache or dizziness. Very rarely, patients may develop muscle spasms (related to altered amino acid levels). The patient leaflet also lists rare effects like joint or muscle pain. In research trials, serious side effects beyond those noted above were uncommon.

  • Renal caution: Since tranexamic acid is excreted by the kidneys, those with impaired renal function need dose adjustments (as above). In kidney failure, accumulation may increase seizure risk.

  • Other precautions: Tell your doctor if you have any problems with blood clotting, if you have a history of eye disease, or neurological conditions. Tranexamic acid can interact with other drugs, particularly clotting factors or thrombolytics: it is contraindicated with prothrombin complex concentrate or factor IX products (risk of clot). Also, if you take hormonal birth control or estrogen, mention it because both can modestly increase clot risk, although the combination is not absolutely contraindicated (but caution is advised).

In case of overdose, symptoms would mainly be hypotension or clotting issues. There is no specific antidote, so treatment is symptomatic and supportive (manage blood pressure, watch kidney function, etc.).

Key Points and Safe Use

  • Tranexamic acid injection (often known by the brand Cyklokapron) is used to prevent or reduce bleeding by blocking the breakdown of clots. It’s given intravenously by trained professionals only (e.g. during surgery or heavy bleeding events).
  • It is commonly dosed at 1 gram IV slowly every 6–8 hours (or 15 mg/kg per dose) for adults, depending on the situation. Pediatric doses are weight-based (about 10–15 mg/kg). Always double-check dosing, especially in children or kidney-impaired patients.
  • Watch for clots: The main risk is unwanted thrombosis. Avoid using it in patients who have active clots, DIC, or serious risk of clots. Monitor for any sign of clot (leg pain/swelling, breathing trouble, chest pain).
  • Allergy: Rare severe allergic reactions can occur. Be ready to treat anaphylaxis if needed (oxygen, epinephrine, etc.) when giving any IV medication.
  • Administration: Inject slowly (generally over 10 minutes or via infusion pump). Rapid injection can cause dangerous hypotension. Do not inject into muscle or elsewhere besides a vein. Always use aseptic technique and properly dispose of needles.
  • Later effects: Inform your doctor of any change in vision or severe headache during therapy. Long-term use (if ever needed) requires eye exams and watching for visual changes.

Disclaimer: I am not a doctor. The information below is for general knowledge and not medical advice. Always follow a healthcare provider’s directions.

Get Notified When Back in Stock